HUP0202151A2 - Stable formulation containing fumagillin - Google Patents

Stable formulation containing fumagillin

Info

Publication number: HUP0202151A2
Authority: HU; Hungary
Prior art keywords: formulation containing; stable formulation; fumagillin; containing fumagillin; stable
Prior art date: 1999-02-26

Application number

HU0202151A

Other languages

Hungarian (hu)

Inventor

Bernard Abramovici

Jean-Luc Dubois

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-26

Filing date

2000-02-21

Publication date

2002-10-28

1999-02-26 Priority claimed from FR9902401A external-priority patent/FR2790200B3/en

1999-07-27 Priority claimed from FR9909702A external-priority patent/FR2796842B3/en

2000-02-21 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2002-10-28 Publication of HUP0202151A2 publication Critical patent/HUP0202151A2/en

2005-02-28 Publication of HUP0202151A3 publication Critical patent/HUP0202151A3/en

2013-06-28 Publication of HU228857B1 publication Critical patent/HU228857B1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

HU0202151A 1999-02-26 2000-02-21 Stable formulation containing fumagillin HU228857B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9902401A FR2790200B3 (en)	1999-02-26	1999-02-26	STABLE FORMULATION CONTAINING FUMAGILLIN
FR9909702A FR2796842B3 (en)	1999-07-27	1999-07-27	STABLE FORMULATION CONTAINING FUMAGILLIN
PCT/FR2000/000424 WO2000050084A1 (en)	1999-02-26	2000-02-21	Stable formulation containing fumagillin

Publications (3)

Publication Number	Publication Date
HUP0202151A2 true HUP0202151A2 (en)	2002-10-28
HUP0202151A3 HUP0202151A3 (en)	2005-02-28
HU228857B1 HU228857B1 (en)	2013-06-28

Family

ID=26234836

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0202151A HU228857B1 (en)	1999-02-26	2000-02-21	Stable formulation containing fumagillin

Country Status (12)

Country	Link
US (1)	US6528539B1 (en)
EP (1)	EP1156829B1 (en)
JP (1)	JP2002537358A (en)
AT (1)	ATE361757T1 (en)
AU (1)	AU2811400A (en)
CY (1)	CY1106807T1 (en)
DE (1)	DE60034770T2 (en)
DK (1)	DK1156829T3 (en)
ES (1)	ES2286998T3 (en)
HU (1)	HU228857B1 (en)
PT (1)	PT1156829E (en)
WO (1)	WO2000050084A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL202691B1 (en) *	2001-09-10	2009-07-31	Hoffmann La Roche	Oily thixotropic formulations
CA2503510C (en) *	2002-09-26	2014-12-02	Probiohealth, Llc	Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
DE102005055385A1 (en) *	2004-12-09	2006-06-14	Bayer Healthcare Ag	Medicines for hygienic application in the ear
DE102007055341A1 (en) *	2007-11-19	2009-05-20	Bayer Animal Health Gmbh	Stabilization of oily suspensions containing hydrophobic silicas
EP2217283A2 (en) *	2007-11-28	2010-08-18	Mersana Therapeutics, Inc.	Biocompatible biodegradable fumagillin analog conjugates
JP5873375B2 (en) *	2012-04-03	2016-03-01	中日本カプセル株式会社	Soft capsule and method for producing soft capsule

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4918103A (en)	1988-07-25	1990-04-17	Formulations Development Labs	Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
EP0602586B1 (en)	1992-12-16	1997-06-04	Takeda Chemical Industries, Ltd.	Stable pharmaceutical composition of fumagillol derivatives
US5900431A (en)	1995-03-27	1999-05-04	Sanofi	Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
EP0799616A1 (en) *	1996-04-01	1997-10-08	Takeda Chemical Industries, Ltd.	Oral composition comprising a fumagillol derivative
JPH1081621A (en) *	1996-04-01	1998-03-31	Takeda Chem Ind Ltd	Medicinal composition for oral administration
US20010025046A1 (en) *	1999-06-24	2001-09-27	Rong(Ron) Liu	Self-emulsifying systems containing anticancer medicament
US6267985B1 (en) *	1999-06-30	2001-07-31	Lipocine Inc.	Clear oil-containing pharmaceutical compositions

2000
- 2000-02-21 ES ES00906438T patent/ES2286998T3/en not_active Expired - Lifetime
- 2000-02-21 AT AT00906438T patent/ATE361757T1/en active
- 2000-02-21 AU AU28114/00A patent/AU2811400A/en not_active Abandoned
- 2000-02-21 JP JP2000600694A patent/JP2002537358A/en active Pending
- 2000-02-21 DE DE60034770T patent/DE60034770T2/en not_active Expired - Lifetime
- 2000-02-21 HU HU0202151A patent/HU228857B1/en unknown
- 2000-02-21 PT PT00906438T patent/PT1156829E/en unknown
- 2000-02-21 US US09/913,547 patent/US6528539B1/en not_active Expired - Lifetime
- 2000-02-21 WO PCT/FR2000/000424 patent/WO2000050084A1/en not_active Ceased
- 2000-02-21 EP EP00906438A patent/EP1156829B1/en not_active Expired - Lifetime
- 2000-02-21 DK DK00906438T patent/DK1156829T3/en active
2007
- 2007-08-08 CY CY20071101062T patent/CY1106807T1/en unknown

Also Published As

Publication number	Publication date
WO2000050084A1 (en)	2000-08-31
EP1156829B1 (en)	2007-05-09
HU228857B1 (en)	2013-06-28
EP1156829A1 (en)	2001-11-28
DK1156829T3 (en)	2007-09-10
ES2286998T3 (en)	2007-12-16
ATE361757T1 (en)	2007-06-15
CY1106807T1 (en)	2012-05-23
US6528539B1 (en)	2003-03-04
JP2002537358A (en)	2002-11-05
HUP0202151A3 (en)	2005-02-28
AU2811400A (en)	2000-09-14
DE60034770D1 (en)	2007-06-21
PT1156829E (en)	2007-08-17
DE60034770T2 (en)	2008-04-30

Legal Events

Date

Code

Title

Description

2014-04-28

HC9A

Change of name, address

Owner name: SANOFI, FR

Free format text: FORMER OWNER(S): SANOFI-SYNTHELABO, FR; SANOFI-AVENTIS, FR

Publication	Publication Date	Title
HUP0201489A3 (en)	2004-05-28	New formulation
SI1052974T1 (en)	2009-10-31	Pharmaceutical formulation containing epothilone
HUP0103707A3 (en)	2004-07-28	Formulation of stable oxalyplatinum solution
AU2001295657A1 (en)	2002-04-22	Formulation containing wax-esters
EG24226A (en)	2008-11-10	Formulation
HUP0000137A3 (en)	2001-03-28	Controller-release pharmaceutical composition containing anangetics
GB9905898D0 (en)	1999-05-05	Controlled-dose formulation
GB9902304D0 (en)	1999-03-24	Formulation
IL148725A0 (en)	2002-09-12	Aqueous pharmaceutical compositions containing circlesonide
IL148543A0 (en)	2002-09-12	Pharmaceutical carrier formulation
HUP0202151A2 (en)	2002-10-28	Stable formulation containing fumagillin
PL344872A1 (en)	2001-11-19	Novel formulation containing paroxetine
GB9909154D0 (en)	1999-06-16	Pharmaceutical formulation
GB9927614D0 (en)	2000-01-19	Sterliant formulation
PL344573A1 (en)	2001-11-05	Novel formulation containing paroxetine
SI1156829T1 (en)	2007-10-31	Stable formulation containing fumagillin
GB9926251D0 (en)	2000-01-12	Pharmaceutical formulation
GB9902236D0 (en)	1999-03-24	Formulation
GB9908776D0 (en)	1999-06-09	Formulation
GB9915584D0 (en)	1999-09-01	Formulation
GB9902089D0 (en)	1999-03-24	Formulation
GB9923538D0 (en)	1999-12-08	Formulation
GB9917952D0 (en)	1999-09-29	Formulation
GB9919060D0 (en)	1999-10-13	Combination formulation
GB9811622D0 (en)	1998-07-29	Drug formulation